ISO-PPADS TETRASODIUM SALT structure
|
Common Name | ISO-PPADS TETRASODIUM SALT | ||
|---|---|---|---|---|
| CAS Number | 207572-67-6 | Molecular Weight | 599.30 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H10N3Na4O12PS2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ISO-PPADS TETRASODIUM SALTIso-PPADS tetrasodium is a P2X-purinoceptor antagonist. Iso-PPADS tetrasodium inhibits P2X1 and P2X3 receptor with IC50s of 43 nM and 84 nM. Iso-PPADS tetrasodium is protective against ventilator-induced brain injury (VIBI)[1][2]. |
| Name | Disodium (2-{2-[(E)-(2,5-disulfophenyl)diazenyl]-4-formyl-5-hydroxy-6-methyl-3-pyridinyl}ethyl)phosphonate |
|---|---|
| Synonym | More Synonyms |
| Description | Iso-PPADS tetrasodium is a P2X-purinoceptor antagonist. Iso-PPADS tetrasodium inhibits P2X1 and P2X3 receptor with IC50s of 43 nM and 84 nM. Iso-PPADS tetrasodium is protective against ventilator-induced brain injury (VIBI)[1][2]. |
|---|---|
| Related Catalog | |
| Target |
43 nM and 84 nM (P2X1 and P2X3 receptor)[2] |
| References |
| Molecular Formula | C14H10N3Na4O12PS2 |
|---|---|
| Molecular Weight | 599.30 |
| Exact Mass | 552.960266 |
| 1,4-Benzenedisulfonic acid, 2-[(E)-2-[4-formyl-5-hydroxy-6-methyl-3-(2-phosphonoethyl)-2-pyridinyl]diazenyl]-, sodium salt (1:2) |
| Disodium (2-{2-[(E)-(2,5-disulfophenyl)diazenyl]-4-formyl-5-hydroxy-6-methyl-3-pyridinyl}ethyl)phosphonate |